Back to 
BARCLAYS PLC
BARCLAYS PLC
CLDX
Showing 0 of 2 quarters
Position history for BARCLAYS PLC's holdings in Celldex Therapeutics, Inc.
As of its Q4 2018 13F, Barclays held 78 shares of CLDX (Celldex Therapeutics).
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.